These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 638014

  • 1. Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum.
    Woodruff MF, Whitehead VL, Speedy G.
    Br J Cancer; 1978 Mar; 37(3):345-55. PubMed ID: 638014
    [Abstract] [Full Text] [Related]

  • 2. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
    Purnell DM, Bartlett GL, Kreider JW, Biro TG.
    Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
    [Abstract] [Full Text] [Related]

  • 3. Failure of preoperative C. parvum vaccine to modify secondary disease following excision of two non-immunogenic murine carcinomas.
    Hewitt HB, Blake ER.
    Br J Cancer; 1978 Aug; 38(2):219-23. PubMed ID: 698036
    [Abstract] [Full Text] [Related]

  • 4. Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy.
    Moore K, McBride WH.
    Br J Cancer; 1983 Jun; 47(6):797-802. PubMed ID: 6860547
    [Abstract] [Full Text] [Related]

  • 5. Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma.
    Woodruff MF, Dunbar N.
    Br J Cancer; 1975 Jul; 32(1):34-41. PubMed ID: 1080671
    [Abstract] [Full Text] [Related]

  • 6. Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice.
    Woodruff MF, Warner NL.
    J Natl Cancer Inst; 1977 Jan; 58(1):111-6. PubMed ID: 299893
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effect of prolonged Corynebacterium parvum and cyclophosphamide administration on the growth of established tumors.
    Fisher B, Wolmark N, Saffer E, Fisher ER.
    Cancer; 1975 Jan; 35(1):134-43. PubMed ID: 1109767
    [Abstract] [Full Text] [Related]

  • 8. Treatment of cancer using Corynebacterium parvum: similarity of two preparations in four animal tumor models.
    Bartlett GL, Kreider JW, Purnell DM.
    Cancer; 1980 Aug 15; 46(4):685-91. PubMed ID: 7397633
    [Abstract] [Full Text] [Related]

  • 9. Fc receptor-bearing and phagocytic cells in syngeneic tumours of C. parvum- and carrageenan-treated mice.
    Thomson AW, Cruickshank N, Fowler EF.
    Br J Cancer; 1979 May 15; 39(5):598-602. PubMed ID: 486317
    [No Abstract] [Full Text] [Related]

  • 10. Effect of C. parvum and active specific immunotherapy on intracerebral transplants of a murine fibrosarcoma.
    Woodruff MF, Hitchcock E, Whitehead VL.
    Br J Cancer; 1977 May 15; 35(5):687-92. PubMed ID: 861152
    [No Abstract] [Full Text] [Related]

  • 11. Antitumor activity of killed Corynebacterium parvum suspensions in a murine mammary adenocarcinoma CaD2) system.
    Purnell DM, Otterstrom JR, Bartlett GL, Kreider JW.
    J Natl Cancer Inst; 1976 Jun 15; 56(6):1171-5. PubMed ID: 994219
    [Abstract] [Full Text] [Related]

  • 12. C. parvum treatment of transplanted rat tumours of spontaneous origin.
    Willmott N, Pimm MV, Baldwin RW.
    Int J Cancer; 1979 Sep 15; 24(3):323-8. PubMed ID: 385514
    [Abstract] [Full Text] [Related]

  • 13. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
    Suit HD, Sedlacek R, Wagner M, Orsi L, Silobrcic V, Rothman KJ.
    Cancer Res; 1976 Apr 15; 36(4):1305-14. PubMed ID: 1260756
    [Abstract] [Full Text] [Related]

  • 14. Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum.
    Likhite VV.
    J Immunol; 1975 Jun 15; 114(6):1736-42. PubMed ID: 1092759
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of concomitant immunity after radiation therapy and immunotherapy in a syngeneic murine tumour system.
    Deneufbourg JM.
    Acta Radiol Oncol; 1982 Jun 15; 21(5):345-8. PubMed ID: 6297254
    [Abstract] [Full Text] [Related]

  • 16. Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancer.
    Thatcher N, Honeybourne D, Wagstaff J, Carroll KB, Barber PV, Morrison JB, Crowther D.
    Br J Dis Chest; 1984 Jan 15; 78(1):89-97. PubMed ID: 6318791
    [Abstract] [Full Text] [Related]

  • 17. Radiolabelling of Corynebacterium parvum and its distribution in mice.
    Sadler TE, Cramp WA, Castro JE.
    Br J Cancer; 1977 Mar 15; 35(3):357-68. PubMed ID: 851511
    [Abstract] [Full Text] [Related]

  • 18. The effects of Corynebacterium parvum and surgery on the Lewis lung carcinoma and its metastases.
    Sadler TE, Castro JE.
    Br J Surg; 1976 Apr 15; 63(4):292-6. PubMed ID: 1276661
    [Abstract] [Full Text] [Related]

  • 19. Responsiveness of senescent mice to the antitumor properties of Corynebacterium parvum.
    Yuhas JM, Ullrich RL.
    Cancer Res; 1976 Jan 15; 36(1):161-6. PubMed ID: 1247995
    [Abstract] [Full Text] [Related]

  • 20. Suppression of the incidence of death with spontaneous tumours in DBA/2 mice after Corynebacterium parvum-mediated rejection of syngeneic tumours.
    Likhite VV.
    Nature; 1976 Feb 05; 259(5542):397-9. PubMed ID: 1250378
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.